DK2023918T3 - Cyclosporiner til behandlingen og forebyggelse af okulære lidelser - Google Patents
Cyclosporiner til behandlingen og forebyggelse af okulære lidelserInfo
- Publication number
- DK2023918T3 DK2023918T3 DK07795039.2T DK07795039T DK2023918T3 DK 2023918 T3 DK2023918 T3 DK 2023918T3 DK 07795039 T DK07795039 T DK 07795039T DK 2023918 T3 DK2023918 T3 DK 2023918T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- cyclosporins
- prevention
- ocular disorders
- methods
- Prior art date
Links
- 208000022873 Ocular disease Diseases 0.000 title abstract 2
- 108010036941 Cyclosporins Proteins 0.000 title 1
- 229930182912 cyclosporin Natural products 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5355—Non-condensed oxazines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Prostheses (AREA)
- Laser Surgery Devices (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80220806P | 2006-05-19 | 2006-05-19 | |
| PCT/US2007/011919 WO2007136759A2 (en) | 2006-05-19 | 2007-05-18 | Method for the treatment and prevention of ocular disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2023918T3 true DK2023918T3 (da) | 2011-04-26 |
Family
ID=37814449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07795039.2T DK2023918T3 (da) | 2006-05-19 | 2007-05-18 | Cyclosporiner til behandlingen og forebyggelse af okulære lidelser |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US8188052B2 (da) |
| EP (1) | EP2023918B1 (da) |
| JP (1) | JP5377293B2 (da) |
| CN (1) | CN101511357B (da) |
| AT (1) | ATE502633T1 (da) |
| AU (1) | AU2007254148B2 (da) |
| CA (1) | CA2652662C (da) |
| DE (1) | DE602007013391D1 (da) |
| DK (1) | DK2023918T3 (da) |
| ES (1) | ES2361635T3 (da) |
| WO (1) | WO2007136759A2 (da) |
| ZA (1) | ZA200810113B (da) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7196161B2 (en) | 2004-10-01 | 2007-03-27 | Scynexis Inc. | 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection |
| NZ554514A (en) * | 2004-10-01 | 2010-10-29 | Scynexis Inc | 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection |
| US7202209B2 (en) * | 2005-07-13 | 2007-04-10 | Allergan, Inc. | Cyclosporin compositions |
| DE602006020152D1 (de) | 2005-09-30 | 2011-03-31 | Scynexis Inc | Arylalkyl- und heteroarylalkyl-derivate von cyclosporin a bei der behandlung und vorbeugung einer virusinfektion |
| AU2006299426B2 (en) | 2005-09-30 | 2012-07-26 | Scynexis, Inc. | Methods and pharmaceutical compositions for the treatment and prevention of hepatitis C infection |
| CA2652662C (en) | 2006-05-19 | 2015-11-03 | Scynexis, Inc. | Methods for the treatment and prevention of ocular disorders |
| US10265265B2 (en) | 2007-03-15 | 2019-04-23 | Drug Delivery Solutions Limited | Topical composition |
| EP2008651A1 (en) | 2007-06-26 | 2008-12-31 | Drug Delivery Solutions Limited | A bioerodible patch |
| EP2280989B1 (en) | 2008-06-06 | 2016-02-10 | Scynexis, Inc. | Cyclosporin analogs and their use in the treatment of hcv infections |
| US20090306033A1 (en) * | 2008-06-06 | 2009-12-10 | Keqiang Li | Novel cyclic peptides |
| WO2010076329A1 (en) | 2008-12-31 | 2010-07-08 | Scynexis, Inc. | Derivatives of cyclosporin a |
| US8685917B2 (en) * | 2009-07-09 | 2014-04-01 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogues |
| CN102869367A (zh) * | 2009-12-09 | 2013-01-09 | 西尼克斯公司 | 新颖的环肽 |
| US9175042B2 (en) * | 2010-10-12 | 2015-11-03 | Allergan, Inc. | Cyclosporin analogs |
| BR112013008864A2 (pt) | 2010-10-12 | 2016-06-28 | Allergan Inc | análogos d ciclosporina |
| ES2736256T3 (es) * | 2011-03-14 | 2019-12-27 | Drug Delivery Solutions Ltd | Composición oftálmica |
| US10429712B2 (en) | 2012-04-20 | 2019-10-01 | View, Inc. | Angled bus bar |
| AU2013267435B2 (en) | 2012-06-01 | 2017-11-09 | Allergan, Inc. | Cyclosporin A analogs |
| RU2019101249A (ru) | 2013-06-18 | 2019-03-05 | Вью, Инк. | Электрохромные устройства непрямоугольных форм |
| CN107430118A (zh) * | 2013-06-27 | 2017-12-01 | 广东盛泽康华生物医药有限公司 | 对自身免疫状况的分类与管理的方法与仪器 |
| US9801862B2 (en) | 2013-11-05 | 2017-10-31 | Gustavo A. Garcia-Sánchez | Immunosuppressive treatments, formulations and methods |
| WO2016112321A1 (en) | 2015-01-08 | 2016-07-14 | Allergan, Inc. | Cyclosporin derivatives wherein the mebmt sidechain has been cyclized |
| KR102084341B1 (ko) * | 2015-12-14 | 2020-03-03 | 요우 핑 차오 | 짧은 합성 펩티드 및 그의 용도 |
| GB201711749D0 (en) * | 2017-07-21 | 2017-09-06 | Cypralis Ltd | Cyclosporin analogues and uses thereof |
| EP3542788A1 (en) | 2018-03-19 | 2019-09-25 | MC2 Therapeutics Limited | Topical composition comprising calcipotriol and betamethasone dipropionate |
| CN111449050A (zh) * | 2019-01-20 | 2020-07-28 | 睿诺医疗科技（上海）有限公司 | 环孢菌素类似物及其用途 |
| US20200366476A1 (en) * | 2019-05-17 | 2020-11-19 | Panasonic Avionics Corporation | Transient key negotiation for passenger accessible peripherals |
| CN114401733A (zh) * | 2019-10-12 | 2022-04-26 | 睿诺医疗科技（上海）有限公司 | 肾毒素诱发的肾损伤的治疗和预防 |
| CN111920940B (zh) * | 2020-09-16 | 2022-04-05 | 易舟(上海)生物医药有限公司 | 一种眼用制剂及其制备方法和应用 |
| KR20220158761A (ko) * | 2020-03-26 | 2022-12-01 | 파사이트 메디컬 테크놀로지 (상하이) 컴퍼니 리미티드 | 사이클로스포린 유도체의 제조 |
| EP4135743A4 (en) | 2020-04-15 | 2024-05-22 | Farsight Medical Technology (Shanghai) Co., Ltd. | Prevention and treatment of organ injuries |
| US11564909B2 (en) * | 2020-11-30 | 2023-01-31 | Romeg Therapeutics Llc | Methods and compositions for oral pilocarpine liquid |
| WO2024245384A1 (en) * | 2023-06-02 | 2024-12-05 | Farsight Medical Technology (Shanghai) Co., Ltd. | Cyclophilin inhibitors and uses thereof |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0194972B1 (en) | 1985-03-11 | 1992-07-29 | Sandoz Ag | Novel cyclosporins |
| US4649047A (en) | 1985-03-19 | 1987-03-10 | University Of Georgia Research Foundation, Inc. | Ophthalmic treatment by topical administration of cyclosporin |
| US4814323A (en) | 1986-03-25 | 1989-03-21 | Andrieu J M | Process for the treatment and the prevention of AIDS and other disorders induced by the LAV/HTLV III virus |
| US4885276A (en) | 1987-06-03 | 1989-12-05 | Merck & Co., Inc. | Cyclosporin analogs with modified "C-9 amino acids" |
| US4798823A (en) | 1987-06-03 | 1989-01-17 | Merck & Co., Inc. | New cyclosporin analogs with modified "C-9 amino acids" |
| US4996193A (en) | 1989-03-03 | 1991-02-26 | The Regents Of The University Of California | Combined topical and systemic method of administration of cyclosporine |
| US5294604A (en) | 1989-12-20 | 1994-03-15 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method of treating ocular diseases by periocular administration of cyclosporine A or G |
| DE69124459T3 (de) | 1990-11-02 | 2001-05-31 | Novartis Ag, Basel | Zyklosporine |
| US5863550A (en) | 1993-03-31 | 1999-01-26 | Tokyo Tanabe Company Limited | Cholestasis ameliorant |
| US5846964A (en) | 1993-07-19 | 1998-12-08 | Tokyo Tanabe Company Limited | Hepatitis C virus proliferation inhibitor |
| ATE209216T1 (de) | 1995-07-17 | 2001-12-15 | Chem Ag C | Cyclosporin-derivate mit anti-hiv-wirkung |
| JP3089350B2 (ja) | 1995-11-20 | 2000-09-18 | ギルフォード ファーマシューティカルズ インコーポレイテッド | シクロフィリンロタマーゼ活性の阻害剤 |
| FR2757522B1 (fr) | 1996-12-24 | 1999-01-29 | Rhone Poulenc Rorer Sa | Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent |
| FR2757521B1 (fr) | 1996-12-24 | 1999-01-29 | Rhone Poulenc Rorer Sa | Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent |
| FR2757520B1 (fr) | 1996-12-24 | 1999-01-29 | Rhone Poulenc Rorer Sa | Derive de cyclosporine, sa preparation et les compositions pharmaceutiques qui le contiennent |
| FR2762843B1 (fr) | 1997-04-30 | 1999-12-10 | Rhone Poulenc Rorer Sa | Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent |
| FR2772768B1 (fr) | 1997-12-19 | 2000-01-14 | Rhone Poulenc Rorer Sa | Nouveau procede de preparation de derives de cyclosporine |
| CA2334730C (en) | 1998-06-12 | 2009-09-29 | C-Chem Ag | Novel cyclosporins |
| FR2780061B1 (fr) | 1998-06-22 | 2001-09-07 | Rhone Poulenc Rorer Sa | Nouveau procede de preparation de derives de cyclosporine |
| DE69928938T2 (de) | 1998-07-01 | 2006-08-17 | Debiopharm S.A. | Neues cyclosporin mit verbesserter wirkung |
| US6254860B1 (en) | 1999-04-13 | 2001-07-03 | Allergan Sales, Inc. | Ocular treatment using cyclosporin-A derivatives |
| US7229961B2 (en) * | 1999-08-24 | 2007-06-12 | Cellgate, Inc. | Compositions and methods for enhancing drug delivery across and into ocular tissues |
| US6521595B1 (en) | 1999-11-19 | 2003-02-18 | Lg Chemical, Ltd. | Nonimmunosuppressive [γ-hydroxy-methylleucine4] cyclosporin A, hair growth stimulator and external composition for skin using the same |
| SK13752001A3 (sk) | 1999-12-27 | 2002-07-02 | Japan Tobacco, Inc. | Zlúčeniny s fúzovanými kruhmi a ich použitie ako liečiv |
| CN1498224A (zh) | 2000-07-21 | 2004-05-19 | ���鹫˾ | 用作丙型肝炎病毒ns3-丝氨酸蛋白酶抑制剂的新型肽 |
| KR20040039622A (ko) | 2002-11-04 | 2004-05-12 | 주식회사 엘지생활건강 | 모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제 |
| US6987090B2 (en) | 2002-05-09 | 2006-01-17 | Lg Household & Health Care Ltd. | Use of 3-position cyclosporin derivatives for hair growth |
| WO2005000308A2 (en) | 2003-05-15 | 2005-01-06 | Rigel Pharmaceuticals, Inc. | Methods of identifying hcv ns5b polymerase inhibitors and use against hepatitis c |
| GB0320638D0 (en) | 2003-09-03 | 2003-10-01 | Novartis Ag | Organic compounds |
| US20050277584A1 (en) * | 2004-06-09 | 2005-12-15 | Allergan, Inc. | Pharmaceutical compositions comprising cyclosporins |
| RU2007105141A (ru) | 2004-07-13 | 2008-08-20 | Новартис АГ (CH) | Применение циклоспоринов для лечения болезни альцгеймера |
| MX2007000503A (es) | 2004-07-14 | 2007-03-08 | Novartis Ag | Uso de una combinacion de ciclosporina e interferon pegilado para el tratamiento de hepatitis c(hcv). |
| JP2008514701A (ja) * | 2004-09-29 | 2008-05-08 | エーエムアール テクノロジー インコーポレイテッド | シクロスポリンアルキン類似体およびそれらの薬学的使用 |
| US7196161B2 (en) | 2004-10-01 | 2007-03-27 | Scynexis Inc. | 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection |
| CA2580448C (en) | 2004-10-01 | 2012-09-18 | Debiopharm Sa | Use of [d-meala]3-[etval]4-cyclosporin for the treatment of hepatitis c infection and pharmaceutical composition comprising said [d-meala]3-[etval]4-cyclosporin |
| NZ554514A (en) | 2004-10-01 | 2010-10-29 | Scynexis Inc | 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection |
| CN101076350A (zh) | 2004-12-23 | 2007-11-21 | 诺瓦提斯公司 | 用于hcv治疗的组合物 |
| CN101084005A (zh) | 2004-12-23 | 2007-12-05 | 诺瓦提斯公司 | 用于黄病毒科治疗的化合物 |
| AU2006299426B2 (en) | 2005-09-30 | 2012-07-26 | Scynexis, Inc. | Methods and pharmaceutical compositions for the treatment and prevention of hepatitis C infection |
| DE602006020152D1 (de) | 2005-09-30 | 2011-03-31 | Scynexis Inc | Arylalkyl- und heteroarylalkyl-derivate von cyclosporin a bei der behandlung und vorbeugung einer virusinfektion |
| CA2652662C (en) | 2006-05-19 | 2015-11-03 | Scynexis, Inc. | Methods for the treatment and prevention of ocular disorders |
| WO2008069917A2 (en) | 2006-11-20 | 2008-06-12 | Scynexis, Inc. | Novel cyclic peptides |
| WO2008127613A1 (en) | 2007-04-11 | 2008-10-23 | Scynexis, Inc. | New pharmaceutical compositions |
| WO2008143996A1 (en) * | 2007-05-18 | 2008-11-27 | Scynexis, Inc. | New chemical processes |
| US20090306033A1 (en) | 2008-06-06 | 2009-12-10 | Keqiang Li | Novel cyclic peptides |
| EP2280989B1 (en) | 2008-06-06 | 2016-02-10 | Scynexis, Inc. | Cyclosporin analogs and their use in the treatment of hcv infections |
| WO2010076329A1 (en) | 2008-12-31 | 2010-07-08 | Scynexis, Inc. | Derivatives of cyclosporin a |
| MX2011007195A (es) | 2009-01-07 | 2013-07-12 | Scynexis Inc | Derivado de ciclosporina para el uso en el tratamiento de infección de virus de hepatitis c (vhc) y virus de inmunodeficiencia humana (vih). |
| CA2748792A1 (en) | 2009-01-07 | 2010-07-15 | Samuel Earl Hopkins | Combination of a cyclosporine derivative and nucleosides for treating hcv |
| CN102869367A (zh) | 2009-12-09 | 2013-01-09 | 西尼克斯公司 | 新颖的环肽 |
-
2007
- 2007-05-18 CA CA2652662A patent/CA2652662C/en active Active
- 2007-05-18 DK DK07795039.2T patent/DK2023918T3/da active
- 2007-05-18 EP EP07795039A patent/EP2023918B1/en active Active
- 2007-05-18 US US12/301,210 patent/US8188052B2/en active Active
- 2007-05-18 ES ES07795039T patent/ES2361635T3/es active Active
- 2007-05-18 AU AU2007254148A patent/AU2007254148B2/en active Active
- 2007-05-18 WO PCT/US2007/011919 patent/WO2007136759A2/en not_active Ceased
- 2007-05-18 CN CN2007800267754A patent/CN101511357B/zh active Active
- 2007-05-18 JP JP2009511089A patent/JP5377293B2/ja active Active
- 2007-05-18 DE DE602007013391T patent/DE602007013391D1/de active Active
- 2007-05-18 AT AT07795039T patent/ATE502633T1/de active
-
2008
- 2008-11-27 ZA ZA2008/10113A patent/ZA200810113B/en unknown
-
2012
- 2012-04-27 US US13/458,460 patent/US8551952B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2007254148B2 (en) | 2013-02-07 |
| US20120270804A1 (en) | 2012-10-25 |
| US8551952B2 (en) | 2013-10-08 |
| EP2023918A2 (en) | 2009-02-18 |
| ATE502633T1 (de) | 2011-04-15 |
| US8188052B2 (en) | 2012-05-29 |
| WO2007136759A3 (en) | 2009-04-16 |
| EP2023918B1 (en) | 2011-03-23 |
| CN101511357B (zh) | 2011-11-02 |
| CA2652662C (en) | 2015-11-03 |
| JP5377293B2 (ja) | 2013-12-25 |
| WO2007136759A2 (en) | 2007-11-29 |
| CN101511357A (zh) | 2009-08-19 |
| ZA200810113B (en) | 2010-02-24 |
| ES2361635T3 (es) | 2011-06-20 |
| DE602007013391D1 (de) | 2011-05-05 |
| US20100062975A1 (en) | 2010-03-11 |
| CA2652662A1 (en) | 2007-11-29 |
| AU2007254148A1 (en) | 2007-11-29 |
| JP2009537550A (ja) | 2009-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2023918T3 (da) | Cyclosporiner til behandlingen og forebyggelse af okulære lidelser | |
| WO2007112014A3 (en) | New therapeutic combinations for the treatment of depression | |
| DK2026803T3 (da) | Sammensætninger af R(+) og S(-) pramipexol og fremgangsmåder til anvendelse heraf | |
| EA200802213A1 (ru) | Способы лечения заболеваний крови | |
| EA200870193A1 (ru) | Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение | |
| MX374396B (es) | Rocio de fentanilo sublingual. | |
| EA201070786A1 (ru) | Бензофуропиримидиноны | |
| NO20083002L (no) | Fremgangsmate for anvendelse av CD40-bindende forbindelser | |
| GB0413087D0 (en) | Therapeutic compounds | |
| EA200802223A1 (ru) | 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90 | |
| ATE506340T1 (de) | 12-aryl-prostaglandin-analoga | |
| MY145795A (en) | Pyrazoline compounds | |
| IS8230A (is) | Setið 2-amínótetralín til notkunar við meðferð á þunglyndi | |
| EA201170703A1 (ru) | Производные адамантилбензамида | |
| TW200738651A (en) | Cyclohexyl sulfonamide derivatives | |
| WO2010004197A3 (fr) | Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique | |
| UA85707C2 (ru) | Бензоксазины для лечения заболеваний дыхательных путей | |
| JO2682B1 (en) | Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof | |
| NO20092690L (no) | Aminderivater og deres anvendelse i beta-2-adrenoreseptormedierte sykdommer | |
| WO2009074247A8 (de) | Neue 2-aryl-thiazol-4-carbonsäureamid-derivate, deren herstellung und verwendung als arzneimittel | |
| WO2008008700A3 (en) | Substituted cyclopentane derivatives as therapeutic agents | |
| BRPI0716643A2 (pt) | amidas terapêuticas e compostos relacionados | |
| MX2009001578A (es) | Lactamas terapeuticas. | |
| EA200900780A1 (ru) | Аналоги эпотилона, модифицированные в положениях c12-c13, как противораковые лекарственные средства | |
| DK1786442T3 (da) | Behandling af neurodegenerative sygdomme under anvendelse af DEGS-inhibitorer |